Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
Chinese Pharmacological Bulletin ; (12): 617-621, 2017.
Article in Chinese | WPRIM | ID: wpr-615848

ABSTRACT

Aim To investigate the antitumor and antiangiogenic effects of combined low-dose cyclophosphamide(CTX)and recombined VEGF protein vaccine.Methods In this experiment,H22 hepatocellular carcinoma model was established in BALB/c mice.Mice were randomly divided into four groups: control group,CTX group(CTX),VEGF protein vaccine group(V2)and CTX plus V2 group(CTX+V2).The anti-tumor efficacy and antiangiogenic effect were investigated using a subcutaneous tumor model and an intradermal tumor model.Western blot and ELISAwere further adopted to detect the specific anti-VEGF antibody.Results CTX+V2 group displayed a lower tumor volume and tumor weight than either the single therapy group in the subcutaneous tumor model(P<005 vs V2,P<001 vs CTX).Meanwhile,CTX+V2 was more effective for antagonizing tumor-associated angiogenesis compared with either the single therapy(P<005 vs V2,P<001 vs CTX).After CTX+V2 immunization,high titer of anti-VEGF antibody was detected by ELISA and verified by Western blot.Conclusion The therapy of CTX combined with V2 has significant synergistic effect against H22 hepatocellular carcinoma.

2.
Chinese Pharmaceutical Journal ; (24): 280-283, 2016.
Article in Chinese | WPRIM | ID: wpr-859204

ABSTRACT

OBJECTIVE: To investigate the effects of Rhaponticum uniflorum extract (RUE) on angiogenesis and apoptosis of H22 transplanted tumor tissue in mice. METHODS: Mice bearing H22 hepatoma cells were randomly assigned into 5 groups: model, high, medium and low dose RUE, and 5-fluorouracil (5-Fu) group. The intervention was lasted for 10 d. The pathological changes were detected with hematoxylin & eosin (HE) staining, the apoptosis of hepatoma cells were determined by DNA laddering method, the microvessel densities (MVD) were detected using immunohistochemical assay, and the protein expression of vascular endothelial growth factor (VEGF), vascular endothelial growth factor receptor 2 (VEGFR2) and hypoxia-inducible factor-1α (HIF-1α) were detected by Western blot method. RESULTS: RUE treatment reduced the cell proliferation, aggravated the necrosis of transplanted tumor tissue, reduced DNA fragmentation of H22 hepatoma cells, decreased MVD of tumor tissue, and down-regulated the protein expression of VEGF, VEGFR2 and HIF-1α of the transplanted tumor tissue, as compared with the model group. CONCLUSION: RUE could exhibit anti-angiogenic and pro-apoptotic effects against H22 hepatoma cells in mice, and its anti-angiogenic mechanism is probably related to down-regulation of VEGF, VEGFR2 and HIF-1α proteins.

3.
Chinese Traditional and Herbal Drugs ; (24): 1343-1347, 2015.
Article in Chinese | WPRIM | ID: wpr-854418

ABSTRACT

Objective: To study the inhibition of polypeptide extract from scorpion venom (PESV) combined with Rapamycin (RAPA) on angiogenesis of H22 hepatoma and its mechanism. Methods: The H22 carcinoma cell suspension was subcutaneously inoculated into 40 Kunming mice. Then tumor-bearing mice were randomly divided into four groups, i.e., control group, PESV group (20 mg/kg), RAPA group (2.5 mg/kg), and PESV + RAPA group, 10 mice in each group. The intervention was lasted 14 d. The tumor volume was measured once every other day, the tumor volume growth curve was drawn, and the tumor inhibitory rate was calculated. The protein expression levels of mammal target of RAPA (mTOR), hypoxia-inducible factor-1α (HIF-1α), and vascular endothelial growth factor-A (VEGF-A) were detected by immunohistochemical assay. Microvessel was signed by factor VIII and then detected by immunohistochemical assay. Results: The growth speed of H22 hepatoma transplantation tumor was obviously inhibited in the PESV group, RAPA group, and PESV + RAPA group compared with control group after 14 d intervention (P 22 hepatoma, the mechanism maybe related to the inhibition on the protein expression of mTOR, HIF-1α, and VEGF-A.

4.
Chinese Traditional and Herbal Drugs ; (24): 2433-2436, 2013.
Article in Chinese | WPRIM | ID: wpr-855162

ABSTRACT

Objective: To study the inhibition and the mechanism of Hygrophorus lucorum polysaccharide (HLP) on H22 transplanted tumor in mice. Methods: The H22 transplanted models of mice were established. Sixty mice were divided into six groups: control, model, cytoxan (CTX, 200 mg/kg) positive control, low-, mid-, and high-dose (50, 100, and 200 mg/kg) HLP groups. On the day 2 after being inoculated with H22 tumor cells, mice were ig given HLP once daily for consecutive 10 d. And then the body weight change, tumor growth inhibitory rate, and spleen and thymus indexes were calculated; the serum levels of TNF-α, IL-2, VEGF, and albumin (Alb) were determined. The activities of SOD, GSH-Px, CAT, and the contents of GSH and MDA in liver homogenates, as well as the number of WBC were detected. Results: The tumor growth inhibitory rate of HLP was over 30%. The treatment with HLP significantly increased the body weight, spleen index, and the number of WBC, elevated the serum levels of IL-2, reduced the VEGF, promoted the hepatic SOD, GSH-Px, CAT activities, and GSH content, and decreased the MDA in liver homogenates. Conclusion: HLP has an antitumor effect on H22 transplanted tumor in mice, and the possible mechanisms may be due to its antioxidant activity, regulation of immunofunction, and anti-angiogenetic action.

5.
Chinese Pharmaceutical Journal ; (24): 1625-1629, 2012.
Article in Chinese | WPRIM | ID: wpr-860590

ABSTRACT

OBJECTIVE: To explore the anti-tumor activities of a new compound 3β,12β,20(S)-trihydroxy dammarane-3-O-β-D-glucopyranosyl (1-2)-β-D-glucopyranoside (HRG), which is a substance of ginsenoside structure modification, in vivo. METHODS: Liver cancer H22 tumor model on the chick chorioallantoic membrane (CAM) was established to observe the effects of HRG on tumor growth, the number of induced vessels and the growth inhibition rate. The implanted tumors were dyed by hematoxylin-eosin (HE), and the morphological properties were studied with light microscope. Immunohistochemistry (SP method) was used to detect the expressions of the implanted tumor's MVD and VEGF. RESULTS: HRG inhibited the tumor growth at 25, 50 and 100 μg · mL-1. Compared with the model control group, the inhibitory rates of the tumor growth were 27.73%, 50.02%, and 64.21%, respectively. HRG significantly reduced the number of tumor-induced vessels. At the same time, there existed different degree necrosis among the treatment groups, and the degree of necrosis had an inverse relationship with the number of tumor-induced vessels. In addition, HRG reduced the MVD of the implanted tumors, and decreased the expression of VEGF. CONCLUSION: HRG has good anti-tumor activities in vivo, and can significantly inhibit the growth of liver cancer H22-CAM tumor and the induction of angiogenesis. The mechanisms may be associated with lower tumor MVD and VEGF expression.

SELECTION OF CITATIONS
SEARCH DETAIL